trans-acting inhibition of genomic RNA dimerization by Rous sarcoma virus matrix mutants

Journal of Virology

Volumn 75, Issue 1, 2001, Pages 260-268

  Garbitt, R A ^a   Albert, J A ^a   Kessler, M D ^a   Parent, L J ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MATRIX PROTEIN; TRANS ACTING FACTOR; VIRUS RNA;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; DIMERIZATION; MYRISTYLATION; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RNA SEQUENCE; RNA TRANSLATION; ROUS SARCOMA ONCOVIRUS; VIRION; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS MUTANT;

ALLELES; AMINO ACID SEQUENCE; AVIAN SARCOMA VIRUSES; BASE SEQUENCE; DIMERIZATION; GENES, GAG; MOLECULAR SEQUENCE DATA; MUTATION; PROVIRUSES; RNA, VIRAL; VIRAL MATRIX PROTEINS;

EID: 0034751052     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.1.260-268.2001     Document Type: Article

References (37)

1. High-molecular-weight RNAs of AKR, NZB, and wild mouse viruses and avian reticuloendotheliosis virus all have similar dimer structures
2. Evidence for the 30-40S RNA as a precursor of the 60-70S RNA of Rous sarcoma virus
3. Comparison of immature (rapid harvest) and mature Rous sarcoma virus particles
4. Genetic analysis of the major homology region of the Rous sarcoma virus Gag protein
5. Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1
6. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses
7. Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein define a requirement for dibasic residues for intracellular cleavage
8. A novel nuclear export activity in HIV-1 matrix protein required for viral replication
9. Specificity of Rous sarcoma virus nucleocapsid protein in genomic RNA packaging
10. Phosphorylated and nonphosphorylated forms of avian sarcoma virus polypeptide p19
11. The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: Possible role in dimerization of genomic RNA and placement of the tRNA on the primer binding site
12. A short autocomplementary sequence plays an essential role in avian sarcoma-leukosis virus RNA dimerization
13. Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and proteasedefective virions
14. Maturation of dimeric viral RNA of Moloneyrnurine leukemia virus
15. Retroviral RNA dimer linkage
16. Role of reverse transcription in retroviral recombination
17. Efficient site-directed mutagenesis using uracil-containing DNA
18. Functional characterization of the human immunodeficiency virus type 1 genome by genetic footprinting
19. A study of the dimerization of Rous sarcoma virus RNA in vitro and in vivo
20. Structure and molecular weight of the 60-70S RNA and the 30-40S RNA of the Rous sarcoma virus
21. Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging
22. Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail
23. Secondary structural features in the 70S RNAs of Moloney murine leukemia and Rous sarcoma viruses as obseved by electron microscopy
24. A large region within the Rous sarcoma virus matrix protein dispensable for budding and infectivity
25. The major site of phosphorylation within the Rous sarcoma virus MA protein is not required for replication
26. Studies of the genomic RNA of leukosis viruses: Implications for RNA dimerization
27. Dimerization of retroviral genomic RNAs: Structural and functional implications
28. RNA dimerization defect in a Rous sarcoma virus matrix mutant
29. Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein
30. Nucelic acid chaperone activity of retroviral nucleocapsid proteins: Significance for viral replication
31. The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors
32. RNA-binding properties of the matrix protein (p19(gag)) of avian sarcoma and leukemia viruses
33. Properties of avian retrovirus particles defective in viral protease
34. Structure of B77 sarcoma virus RNA: Stabilization of RNA after packaging
35. Incorporation of chimeric Gag protein into retroviral particles
36. Creation and expression of myristylated forms of Rous sarcoma virus Gag protein in mammalian cells
37. Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60(src)